| Literature link | GPT Summary | Evidence category | Disease type |
|---|---|---|---|
| 35926094 | This study aimed to identify and validate differentially expressed miRNAs in plasma exosomes from women with GDM and those with NGT. Using high-throughput sequencing and real-time qPCR, the researchers found 22 exosomal miRNAs, with five significantly altered miRNAs (miR-423–5p, miR-122–5p, miR-148a-3p, miR-192–5p, and miR-99a-5p). These miRNAs are involved in insulin and AMPK signaling pathways, suggesting their role in metabolic regulation in GDM. The five miRNAs showed a high accuracy (AUC=0.82) in predicting GDM early. |
Risk factor |
GDM |
| 31058973 | The study aimed to explore the role of placenta-derived miRNAs in the development of GDM by comparing miRNA expression in EVs from the serum of women who developed GDM and healthy controls during early pregnancy. The researchers found that ten miRNAs, including hsa-miR-122-5p, had significantly higher levels in GDM cases compared to controls, suggesting that these miRNAs could play a role in the pathophysiology of GDM and offer a potential biomarker for early diagnosis. | Risk factor | GDM |
RF's name
hsa-miR-122-5p
RF's type
miRNA